Skip to main content

Futura Medical "confident of getting FDA approval this quarter"

Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive following the release of full year results for 2022.

Barder says that despite losses, revenues "are now rapidly coming over the horizon" and he suggests "the last two years have been very very good for us".

He adds that he's "confident of getting FDA approval for MED3000 this quarter"

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.